Lidocain Hwi Pharma

Lidocaine, the active ingredient in Lidocain Hwi Pharma, is a local anesthetic presented as a rectal formulation for local anesthesia and analgesia. It is used to numb tissue and relieve pain in the rectal area. GNH USA supplies Lidocain Hwi Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is a local anesthetic that works on peripheral nerves to provide temporary loss of sensation. - Rectal anesthesia: provides localized numbness for minor procedures or examinations of the rectal mucosa. - Analgesia: reduces discomfort associated with hemorrhoidal disease or proctologic irritation. - Pain relief: offers short‑term relief of acute rectal pain following minor trauma or surgery.

Lidocaine may cause a range of adverse reactions, most of which are mild and localized.

Common Side Effects: - Local irritation: mild burning, itching or redness at the application site. - Nausea: occasional feeling of queasiness after absorption. - Dizziness: transient light‑headedness. - Headache: mild headache in some patients.

Serious or Rare Side Effects: - Systemic toxicity: seizures, cardiac arrhythmia or hypotension with excessive absorption. - Allergic reaction: rash, urticaria, angioedema or anaphylaxis. - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery. - Severe local tissue damage: ulceration or necrosis if applied to compromised mucosa.

Before using Lidocain Hwi Pharma, consider the following safety measures. - Allergy assessment: confirm the patient has no known hypersensitivity to lidocaine or other amide‑type anesthetics. - Dose limitation: avoid exceeding the maximum recommended amount for rectal administration. - Hepatic impairment: use with caution in patients with liver dysfunction, as metabolism may be reduced. - Cardiac conditions: monitor patients with conduction disorders or arrhythmias. - Concomitant local anesthetics: avoid simultaneous use to prevent additive toxicity. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lidocaine can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of cardiotoxicity. - Beta‑blockers: may enhance lidocaine’s negative inotropic effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): raise systemic lidocaine concentrations.

Moderate Interactions (Monitor Closely): - Other local anesthetics: additive neuro‑ and cardiotoxic effects. - Diuretics (e.g., furosemide): may increase plasma levels by reducing clearance. - General anesthetics (e.g., propofol): potential potentiation of central nervous system depression.